Paediatrics Search
Paediatrics Paediatrics
mumps
MUMPS
Mumps is a self-limited viral disease characterized by nonsuppurative swelling and tenderness of one or both parotid glands.
It commonly affects the children aged 2-12 years and very uncommon in <1 year of age.
It is caused by a single-stranded RNA virus classified under Paramyxoviridae family or mumps virus.
Transmission is through airborne droplets from respiratory secretion of infected persons.
Incubation period is typically 14-21 days.

Prevention

Mumps Vaccine

  • Available as a single-antigen preparation or combined w/ other vaccines [eg mumps & rubella (MMR), or also w/ varicella (MMRV)]
    • Single-antigen is not routinely recommended
    • Based on several studies, a single dose of MMR is 75-91% effective while vaccine effectiveness of 88% is seen w/ 2 doses
    • MMRV is approved for use in healthy children 1-12 yrs of age
  • Single-antigen (MMR) is indicated for children ≥1 yr of age w/ low risk for mumps exposure
  • Second-dose MMR is indicated for children 4-6 yr of age at high risk for mumps exposure
  • Second dose should be given >1 mth after the 1st dose
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Managing bleeding disorders in primary care
Joyce Lam Ching Mei, 28 Mar 2019
April 17 marks World Haemophilia Day, and this year’s theme is  “Reaching Out – The First Step to Care”. Adjunct Assoc Prof Joyce Lam Ching Mei, head of the Haematology Laboratory and Blood Bank and senior consultant from the Paediatric Haematology/Oncology Service at KK Women’s and Children’s Hospital, Singapore, speaks to Elaine Soliven on the importance of recognizing and managing bleeding disorders in primary care.
Preventive zinc, micronutrient powders do not improve child growth
02 Apr 2019
Using preventive zinc and micronutrient powder supplementation does not appear to improve growth in children, a recent study has found.
Breastfeeding boosts key metabolites for brain growth in VLBW babies
Pearl Toh, 01 May 2019
Preterm infants with very low birth weight (VLBW) who were breastfed have significantly higher levels of metabolites important for brain growth and development in their brain tissue compared with formula-fed infants, suggesting that breastfed infants have improved cerebral metabolism at term-equivalent age, according to a study presented at the PAS 2019 Meeting.